Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<Group xmlns="http://hl7.org/fhir">
<id value="189713"/>
<meta>
<versionId value="3"/>
<lastUpdated value="2026-08-05T07:33:36.353Z"/>
</meta>
<language value="en"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Group 189713</b></p><a name="189713"> </a><a name="hc189713"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 3; Last updated: 2026-08-05 07:33:36+0000</p></div><p><b>ArtifactPublicationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}">Active</span></p><p><b>Artifact Author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><p><b>CiteAs</b>: </p><div><p>NCT04401202 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 189713. Revised 2026-08-05. Available at: https://fevir.net/resources/Group/189713. Computable resource at: https://fevir.net/resources/Group/189713#json.</p>
</div><p><b>url</b>: <a href="https://fevir.net/resources/Group/189713">https://fevir.net/resources/Group/189713</a></p><p><b>identifier</b>: FEvIR Object Identifier/189713, FEvIR Linking Identifier/NCT04401202 Eligibility Criteria</p><p><b>name</b>: NCT04401202_Eligibility_Criteria</p><p><b>title</b>: NCT04401202 Eligibility Criteria</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Inclusion Criteria:</p>
<ul>
<li>Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia</li>
<li>Adult (18 Years and above)</li>
<li>Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).</li>
<li>Understands and agrees to comply with planned study procedures.</li>
<li>Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.
Exclusion Criteria:</li>
<li>Patients with pneumonia or severe illness requiring admission to ICU.</li>
<li>Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis</li>
<li>Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).</li>
<li>Pregnancy or breast feeding.</li>
<li>Anticipated transfer to another hospital which is not a study site within 72 hours.</li>
<li>Allergy to any study medication.</li>
</ul>
</div><p><b>copyright</b>: </p><div><p>Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).</p>
</div><p><b>membership</b>: Conceptual</p><p><b>combinationMethod</b>: All of</p><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Adult (18 Years and above)</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Adult (18 Years and above)</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Understands and agrees to comply with planned study procedures.</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Understands and agrees to comply with planned study procedures.</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Patients with pneumonia or severe illness requiring admission to ICU.</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Patients with pneumonia or severe illness requiring admission to ICU.</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal).</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Pregnancy or breast feeding.</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Pregnancy or breast feeding.</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Anticipated transfer to another hospital which is not a study site within 72 hours.</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Anticipated transfer to another hospital which is not a study site within 72 hours.</p>
</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">Defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">Allergy to any study medication.</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Allergy to any study medication.</p>
</div></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
<code value="active"/>
<display value="Active"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<name
value="Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"/>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as">
<valueMarkdown
value="NCT04401202 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 189713. Revised 2026-08-05. Available at: https://fevir.net/resources/Group/189713. Computable resource at: https://fevir.net/resources/Group/189713#json."/>
</extension>
<url value="https://fevir.net/resources/Group/189713"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net/FOI"/>
<value value="189713"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="NCT04401202 Eligibility Criteria"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name value="NCT04401202_Eligibility_Criteria"/>
<title value="NCT04401202 Eligibility Criteria"/>
<status value="active"/>
<publisher value="Computable Publishing LLC"/>
<contact>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</contact>
<description
value="Inclusion Criteria:
* Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia
* Adult (18 Years and above)
* Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).
* Understands and agrees to comply with planned study procedures.
* Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.
Exclusion Criteria:
* Patients with pneumonia or severe illness requiring admission to ICU.
* Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis
* Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal).
* Pregnancy or breast feeding.
* Anticipated transfer to another hospital which is not a study site within 72 hours.
* Allergy to any study medication."/>
<copyright
value="Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."/>
<membership value="conceptual"/>
<combinationMethod value="all-of"/>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia"/>
</valueCodeableConcept>
<exclude value="false"/>
<description
value="Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia"/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text value="Adult (18 Years and above)"/>
</valueCodeableConcept>
<exclude value="false"/>
<description value="Adult (18 Years and above)"/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)."/>
</valueCodeableConcept>
<exclude value="false"/>
<description
value="Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)."/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Understands and agrees to comply with planned study procedures."/>
</valueCodeableConcept>
<exclude value="false"/>
<description
value="Understands and agrees to comply with planned study procedures."/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH."/>
</valueCodeableConcept>
<exclude value="false"/>
<description
value="Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH."/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Patients with pneumonia or severe illness requiring admission to ICU."/>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Patients with pneumonia or severe illness requiring admission to ICU."/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis"/>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis"/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal)."/>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal)."/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text value="Pregnancy or breast feeding."/>
</valueCodeableConcept>
<exclude value="true"/>
<description value="Pregnancy or breast feeding."/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Anticipated transfer to another hospital which is not a study site within 72 hours."/>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Anticipated transfer to another hospital which is not a study site within 72 hours."/>
</characteristic>
<characteristic>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text value="Allergy to any study medication."/>
</valueCodeableConcept>
<exclude value="true"/>
<description value="Allergy to any study medication."/>
</characteristic>
</Group>